A prospective open label non randomized clinical trial To Evaluate The Safety And efficacy of Endotone polyherbal capsule in treatment of Endometriosis.

Charak Pharma Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年11月21日

试验速览

暂无简介。

•1) Female 18 to 45 years of age (inclusive) at the time of screening.
•2) Women experiencing endometriosis symptoms like pelvic pain, dysmenorrhea,
•Dyspareunia
•3) Women with documented diagnosis of endometriosis by either of the following -
•a) Laparoscopy or laparotomy
•b) VAS test score of 1-7 for dysmenorrhea/dyspareunia and/or Pelvic pain due to
•endometriosis.
•c) Clinical features, pelvic examination findings
•d) Diagnosed case of endometriosis by any radio-imaging techniques.
•4) Recurrent Endometriosis after surgery

•1) Participant having chronic pelvic pain that is not caused by endometriosis
•2) Patients with concomitant hormonal treatment, including oral contraceptive pills.
•3)Patients with known systemic diseases (e.g., hypertension, diabetes, coronary, renal, and
•hepatic diseases).
•4) Patients with known malignancy.
•5) Menopausal women, Pregnancy, Lactating women.
•6) Large chocolate cysts

发起方

Charak Pharma Pvt Ltd